"Avesthagen's core activities are in the integrated biotechnology and information technology platform that basically addresses new discovery and innovation that through partnering with Pharma, Food and the Diagnostic companies."

"The Pharma majors are at the moment we are partnering with CIPLA where we are in pipeline with six new biotherapeutics and which will enter the market 2-3 three years from now and we also have partnership where we are partnering in R&D for AstraZeneca."